Solid Biosciences Inc.
HealthcareNASDAQ:SLDB · NASDAQ Global Select
-$0.08 today
Vol 1.55M · Avg 1.13M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+58.31%
Period High
$8.63
Period Low
$3.93
Latest
$7.14
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
RAPT Therapeutics, Inc.
RAPT
$959.26M
LB Pharmaceuticals Inc Common Stock
NASDAQ:LBRX
$814.99M
Design Therapeutics, Inc.
NASDAQ:DSGN
$685.15M
Annexon, Inc.
NASDAQ:ANNX
$563.29M
Autolus Therapeutics plc
NASDAQ:AUTL
$415.18M
Aura Biosciences, Inc.
NASDAQ:AURA
$411.52M
Neumora Therapeutics, Inc. Common Stock
NASDAQ:NMRA
$329.81M
Rocket Pharmaceuticals, Inc.
NASDAQ:RCKT
$300.28M
Benitec Biopharma Inc.
NASDAQ:BNTC
$293.44M
Quantum-Si incorporated
NASDAQ:QSI
$187.28M
What is the latest SLDB filing?
The latest filing shown is 4 dated Jun 11, 2026.
How many recent filings does SLDB have?
Intrinsic Alpha currently shows 20 recent filings for SLDB.
Explore More
Continue the stock analysis
Jump to another research area for this company.